Biofilm, resistance, and quorum sensing: The triple threat in bacterial pathogenesis

ABSTRACT Bacterial pathogenesis is increasingly defined by the synergistic interplay of three formidable mechanisms: biofilm formation, antimicrobial resistance (AMR), and quorum sensing (QS). Together, these factors enable pathogens to persist in hostile environments, evade immune defenses, and resist conventional therapies, thereby contributing to chronic, device-associated, and recurrent infections. This review explored the molecular and physiological underpinnings of biofilm development and its role as a protective niche that enhances bacterial survival and resistance. It further examines the evolution and dissemination of AMR within biofilm communities, and the role of QS in coordinating virulence, resistance gene expression, and polymicrobial interactions. Clinical implications, including diagnostic challenges, therapeutic failures, and the burden of persistent infections in cystic fibrosis, chronic wounds, and indwelling medical devices, are critically analyzed. Emerging strategies—such as quorum-sensing inhibitors, biofilm-dispersing agents, nanocarriers, engineered bacteriophages, and electroceuticals—offer promising avenues but face translational barriers. Additionally, we highlight a novel therapeutic approach involving multifunctional microbial metabolites such as zincmethylphyrins and coproporphyrins produced by Sphingopyxis species. These compounds promote the growth of previously unculturable microbes via interspecies mutualism while exhibiting cytotoxicity against their producer, suggesting a unique potential as context-dependent antimicrobial agents. By integrating recent advances, this review underscores the urgent need for biofilm-aware diagnostics, anti-virulence strategies, and precision-targeted therapeutics to address the convergence of biofilm, resistance, and quorum sensing in modern bacterial pathogenesis.